Fig. 4From: Monitoring therapeutic efficacy of sunitinib using [18F]FDG and [18F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinomaSunitinib effect on blood vessel size. Comparison of the proportion of small, medium and large vessels between the control and treated groups (set A of mice)Back to article page